poisar

Stocks · News reference

Symbotic Has ‘Plenty’ of Catalysts Ahead, So Why Is This Analyst Slashing the Price Target?

BenzingaPriya Nigam

Needham keeps Symbotic at Buy but cuts PT to $60, citing share price underperformance. Catalysts include new customers, backlog repricing.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading